Federal Pharma Capital
Education · Lobbying Client
C
Influence Score
40/100
Moderate Influence
$1.2M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door
Federal Pharma Capital reported $1.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Education, Science/Technology, Government Issues. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Energy
US House of Representatives
Centers for Medicare & Medicaid Services
Securities & Exchange Commission
Dept of Transportation
Small Business Administration
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Covington & Burling LLP | APP | 1 | $64K |
| 2020 Apr-Jun | Brownstein Hyatt LLP | EDUGOV | 1 | $89K |
| 2020 Jul-Sep | Covington & Burling LLP | GOVAPPSCI | 1 | $70K |
| 2020 Oct-Dec | Squire Patton Boggs LLP | APPSCIGOV+1 | 1 | $64K |
| 2021 Jan-Mar | Akin Gump LLP | EDU | 1 | $47K |
| 2021 Apr-Jun | Squire Patton Boggs LLP | EDUSCIAPP | 1 | $54K |
| 2021 Jul-Sep | K&L Gates LLP | SCI | 1 | $59K |
| 2021 Oct-Dec | BGR Group LLP | SCIAPP | 1 | $53K |